Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer

다국어 초록 (Multilingual Abstract)

Purpose: Although nodal metastasis is the most powerful prognostic factor in rectal cancer, marked heterogeneity exists within stage III rectal cancer. Recent studies of rectal cancer have shown a prognostic superiority of the lymph node ratio (LNR) compared with N stage. The purpose of this study was to investigate the prognostic value of the LNR in the era of the 7th edition of the TNM classification.
Methods: We included 190 patients who underwent a curative resection for rectal cancer with nodal metastasis. The patients were divided into four groups on the basis of statistically calculated cut-off values as 0.21, 0.32, and 0.61.
Results: The LNR was an independent risk factor for overall survival (OS; P = 0.008) and for systemic recurrence-free survival (SRFS; P = 0.002). However, the LNR was not a predictive factor for local recurrence. When the N stage of the sixth TNM staging system was separately analyzed as a covariate, the LNR was also found to be a predictive factor for both OS and SRFS (P = 0.012 and P = 0.004, respectively). A LNR value of 0.21 offered the best cut off to separate patients into two prognostic groups.
Conclusion: The defined cut-off values of the LNR were an independent risk factor for OS and distant metastasis-free survival in patients with rectal cancer, irrespective of the sixth or the seventh version of the TNM classification, and the LNR should be considered as a prognostic variable in any future staging system.

참고문헌 (Reference)

1 Puppa G, "TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues" 134 : 837-852, 2010

2 Zaheer S, "Surgical treatment of adenocarcinoma of the rectum" 227 : 800-811, 1998

3 den Dulk M, "Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial" 246 : 83-90, 2007

4 Gunderson LL, "Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes" 28 : 256-263, 2010

5 Gunderson LL, "Revised TN categorization for colon cancer based on national survival outcomes data" 28 : 264-271, 2010

6 Ceelen W, "Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review" 17 : 2847-2855, 2010

7 De Ridder M, "Prognostic value of the lymph node ratio in node positive colon cancer" 55 : 1681-, 2006

8 Peng J, "Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer" 15 : 3118-3123, 2008

9 Rinkus KM, "Prognostic significance of nodal disease following preoperative radiation for rectal adenocarcinoma" 68 : 482-487, 2002

10 Lee HY, "Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma" 14 : 1712-1717, 2007

11 Rosenberg R, "Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period" 248 : 968-978, 2008

12 Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer" 351 : 1731-1740, 2004

13 Kapiteijn E, "Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer" 345 : 638-646, 2001

14 Mekenkamp LJ, "Pathology Review Committee and the Co-operative Clinical Investigators. Lymph node retrieval in rectal cancer is dependent on many factors: the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist" 33 : 1547-1553, 2009

15 Park IJ, "Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio" 100 : 240-243, 2009

16 Greene FL, "New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis" 22 : 1778-1784, 2004

17 Dekker JW, "Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification" 36 : 1180-1186, 2010

18 Goldstein NS, "Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities" 26 : 179-189, 2002

19 Kobayashi H, "Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study" 26 : 891-896, 2011

20 Baxter NN, "Lymph node evaluation in colorectal cancer patients: a population-based study" 97 : 219-225, 2005

21 Kim YS, "LYMPH NODE RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH STAGE III RECTAL CANCER TREATED WITH TOTAL MESORECTAL EXCISION FOLLOWED BY CHEMORADIOTHERAPY" Elsevier 74 : 796-802, 2009

22 Cook EF, "Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis" 37 : 721-731, 1984

23 Moug SJ, "Comparison of positive lymph node ratio with an inflammation- based prognostic score in colorectal cancer" 98 : 282-286, 2011

24 Berger AC, "Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes" 23 : 8706-8712, 2005

25 Breiman L, "Classification and Regression Trees" Wadsworth International Group 1984